Method Development and Validation of Identity Test for Pneumococcal Polysaccharides and CRM197 Carrier Protein in Pneumococcal Conjugate Vaccine by Slot Blot Assay

Authors

  • Katsama Boonmak Institute of Biological Products, Department of Medical Sciences, Nonthaburi.
  • Supaporn Chumpol Institute of Biological Products, Department of Medical Sciences, Nonthaburi.
  • Apichai Supasarnsathorn Institute of Biological Products, Department of Medical Sciences, Nonthaburi.
  • Supaporn Phumiamorn Medical Sciences Technical Office, Department of Medical Sciences, Nonthaburi, Thailand.

Keywords:

streptococcus pneumoniae, pneumococcal conjugate vaccine, slot blot assay, dossier registration

Abstract

Background: Identity testing is a crucial process that should be conducted on the pneumococcal conjugate vaccine to verify its identity for quality control purposes. The vaccine consists of purified polysaccharides from each serogroup of Streptococcus pneumoniae, conjugated with diphtheria cross-reactive material (CRM197), as specified in the registration dossier. Therefore, this testing ensures that recipients can trust the quality, efficacy, and safety of the vaccine. The identity test of the pneumococcal conjugate vaccine is a newly developed identity testing method by the Institute of Biological Products.

Objective: To develop and validate a standard method for identity testing of pneumococcal polysaccharides and the CRM197 carrier protein using the slot blot assay to verify the identity of the pneumococcal conjugate vaccine.

Methods: The optimum conditions were determined based on the specific reaction between the antigen and antibody, making them suitable for testing. Additionally, method validation was confirmed for two parameters including specificity and intermediate precision.

Results: The results of the optimum conditions for the identity test of pneumococcal polysaccharides and the carrier protein diphtheria Cross Reactive Material (CRM197) in pneumococcal conjugate vaccines, using the slot blot assay, demonstrated that each antigen was specific to its corresponding serotype antibody, leading to the formation of an antigen-antibody complex. Therefore, this method must be performed according to the specified protocol to accurately verify the identity of the vaccine. Validation results revealed high specificity: pneumococcal conjugate vaccine samples displayed distinct dark purple bands, indicating positive identification, while meningococcal vaccine samples showed a negative result, represented by a white band on the nitrocellulose membrane. Furthermore, intermediate precision was confirmed by two independent analysts, both of them obtained consistent results. In both cases, dark purple bands appeared on the nitrocellulose membrane, indicating positive identification. Therefore, this method successfully passed validation and can be adopted as a standard procedure.

Conclusions: The study results revealed that the identity test for pneumococcal polysaccharides and the CRM197 carrier protein using the slot blot assay met the validation requirements. Consequently, it is suitable for use as a standard method for the registration of the pneumococcal conjugate vaccine in Thailand.

References

1. กรมควบคุมโรค กระทรวงสาธารณสุข. ตําราวัคซีนและการสร้างเสริมภูมิคุ้มกันโรค: วัคซีนป้องกันโรคไข้กาฬหลังแอ่น. กรุงเทพฯ: เวิร์คพริ้นท์; 2562.

2. Centers for Disease Control and Prevention. Pneumococcal vaccination [Internet]. [cited 2024 Jul 23]. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/index.html

3. World Health Organization. Annex 3 recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines. Geneva; 2011. Technical Report Series No. 977.

4. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of analytical procedures: text and methodology Q2(R1) [Internet]. 2005 [cited 2024 Jul 16]. Available from: https://www.gmp-compliance.org/files/guidemgr/Q2(R1).pdf

5. Bio-Rad Laboratories. Bio-Dot® SF microfiltration apparatus instruction manual [Internet]. [cited 2024 Jul 12]. Available from: https://www.bio-rad.com/webroot/web/pdf/lsr/literature/M1706542.pdf

6. Brown T. Analysis of RNA by northern and slot-blot hybridization. Curr Protoco Immunology [Internet]. 2001 May;Chapter 10:Unit 10.12 [cited 2024 Jul 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/18432675/#:~:text=Specific%20sequences%20in%20R20RNA%20preparations,by%20slot%20or%20dot%20blotting doi: 10.1002/0471142735.im1012s07. PMID: 18432675

7. Hamm M, Ha S, Rustandi RR. Automated capillary western dot blot method for the identity of a 15-valent pneumococcal conjugate vaccine. Anal Biochem [Internet]. 2015 [cited 2024 Jul 18]; 478:33-9. Available from: https://pubmed.ncbi.nlm.nih.gov/25813208/ doi: 10.1016/j.ab.2015.03.021. Epub 2015 Mar 23. PMID: 25813208

8. Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, et al. Pre - clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine [Internet]. 2011 [cited 2024 Jul 19]; 29:8870-6. Available from: https://pubmed.ncbi.nlm.nih.gov/21964055/ doi: 10.1016/j.vaccine.2011.09.078. Epub 2011 Oct 1. PMID: 21964055

Downloads

Published

27-02-2025

How to Cite

1.
Boonmak K, Chumpol S, Supasarnsathorn A, Phumiamorn S. Method Development and Validation of Identity Test for Pneumococcal Polysaccharides and CRM197 Carrier Protein in Pneumococcal Conjugate Vaccine by Slot Blot Assay. Thai Food and Drug J [internet]. 2025 Feb. 27 [cited 2025 Mar. 15];32(1):47-59. available from: https://he01.tci-thaijo.org/index.php/fdajournal/article/view/277540

Issue

Section

Research Articles